US Patent 7906123 Modified
All edits
Edits on 27 Nov, 2023
Golden AI
Edits made to:
Article (+501 characters)
Article
Patent abstract
The invention relates to modified Bordetella adenylate cyclase toxins which are deficient for CD11b/CD18 binding and to their use in the preparation of pharmaceutical composition for the treatment of whooping cough and/or for the protection against Bordetella infection. The invention also relates to specific fragments of Bordetella adenylate cyclase comprising the CD11b/CD18 interaction domain and their use, especially for targeting a molecule of interest to CD11b expressing cells.
Edits on 19 Sep, 2023
Golden AI
Edits made to:
Infobox (+7 properties)
Infobox
Patent Inventor Names
Claude Leclerc0
Cécile Bauche0
Daniel Ladant0
Jirina Loucka0
Mohammed El-Azami El-Idrissi0
Peter Sebo0
Radim Osicka0
Edits on 24 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 18 May, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07906123 Modified US Patent 7906123 Modified
Infobox
Patent Number
079061230
Patent Number
79061230
Edits on 29 Apr, 2023
Golden AI
Infobox
Is a
Patent Jurisdiction
Patent Number
079061230
Date of Patent
March 15, 2011
0Patent Application Number
117137080
Date Filed
March 5, 2007
0Official Website
Patent Primary Examiner
Edits on 4 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 7 Dec, 2021
Golden AI
Edits made to:
Infobox (+7 properties)
US Patent 07906123 Modified
Infobox
Is a
Patent jurisdiction
Patent number
07906123
Date of patent
March 15, 2011
Patent application number
11713708
Date Filed
March 5, 2007
Patent primary examiner
Find more entities like US Patent 7906123 Modified
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
